ENDRA Life Sciences 55336VAK6 Bond

NDRA Stock  USD 6.05  0.21  3.60%   
ENDRA Life Sciences holds a debt-to-equity ratio of 0.046. At present, ENDRA Life's Short and Long Term Debt Total is projected to decrease significantly based on the last few years of reporting. The current year's Short Term Debt is expected to grow to about 211.5 K, whereas Net Debt is forecasted to decline to (2.6 M). With a high degree of financial leverage come high-interest payments, which usually reduce ENDRA Life's Earnings Per Share (EPS).

Asset vs Debt

Equity vs Debt

ENDRA Life's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. ENDRA Life's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps ENDRA Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect ENDRA Life's stakeholders.
For most companies, including ENDRA Life, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for ENDRA Life Sciences, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, ENDRA Life's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
0.4747
Book Value
27.232
Return On Assets
(0.61)
Return On Equity
(1.20)
At present, ENDRA Life's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Non Current Liabilities Total is expected to grow to about 251.3 K, whereas Liabilities And Stockholders Equity is forecasted to decline to about 6.6 M.
  
Check out the analysis of ENDRA Life Fundamentals Over Time.
View Bond Profile
Given the importance of ENDRA Life's capital structure, the first step in the capital decision process is for the management of ENDRA Life to decide how much external capital it will need to raise to operate in a sustainable way. Once the amount of financing is determined, management needs to examine the financial markets to determine the terms in which the company can boost capital. This move is crucial to the process because the market environment may reduce the ability of ENDRA Life Sciences to issue bonds at a reasonable cost.
Popular NameENDRA Life MPLX LP 4125
SpecializationHealth Care Equipment & Services
Equity ISIN CodeUS29273B1044
Bond Issue ISIN CodeUS55336VAK61
S&P Rating
Others
Maturity Date1st of March 2027
Issuance Date10th of February 2017
Coupon4.125 %
View All ENDRA Life Outstanding Bonds

ENDRA Life Sciences Outstanding Bond Obligations

Dana 575 percentUS235822AB96Details
Volcan Compania MineraUSP98047AC08Details
Boeing Co 2196US097023DG73Details
ENERGY TRANSFER PARTNERSUS29273RAP47Details
ENERGY TRANSFER PARTNERSUS29273RAR03Details
ENERGY TRANSFER PARTNERSUS29273RAJ86Details
ENERGY TRANSFER PARTNERSUS29273RAZ29Details
ENERGY TRANSFER PARTNERSUS29273RAT68Details
ET 783107 01 NOV 66US29273RBA68Details
ENERGY TRANSFER PARTNERSUS29273RBC25Details
ENERGY TRANSFER PARTNERSUS29273RBD08Details
ENERGY TRANSFER PARTNERSUS29273RBJ77Details
ET 555 15 FEB 28US29273VAP58Details
ENERGY TRANSFER PARTNERSUS29273RBK41Details
ET 575 15 FEB 33US29273VAQ32Details
ENERGY TRANSFER PARTNERSUS29273RBL24Details
ENERGY TRANSFER PARTNERSUS29273RBE80Details
ET 675US29273VAL45Details
ENERGY TRANSFER PARTNERSUS29273RBF55Details
Energy Transfer 7125US29273VAM28Details
ENERGY TRANSFER PARTNERSUS29273RBG39Details
US29273VAN01US29273VAN01Details
ENERGY TRANSFER OPERUS29278NAG88Details
ENERGY TRANSFER OPERUS29278NAD57Details
ENERGY TRANSFER OPERUS29278NAE31Details
ENERGY TRANSFER OPERUS29278NAF06Details
ENERGY TRANSFER OPERATINGUS29278NAQ60Details
ENERGY TRANSFER PARTNERSUS29273RAF64Details
ENERGY TRANSFER OPERATINGUS29278NAR44Details
ENERGY TRANSFER OPERATINGUS29278NAP87Details
ENERGY TRANSFER OPERATINGUS29278NAN30Details
HSBC Holdings PLCUS404280DR76Details
MPLX LP 4875US55336VAG59Details
ENERGIZER HLDGS INCUS29272WAD11Details
ENERGIZER HLDGS INCUS29272WAC38Details
US29279XAA81US29279XAA81Details
US29272WAF68US29272WAF68Details
MPLX LP 4125US55336VAK61Details
MPLX LP 52US55336VAL45Details
International Game TechnologyUS460599AD57Details
ENEL CHILE SUS29278DAA37Details
EnerSys 4375 percentUS29275YAC66Details
BNP Paribas FRNUSF1R15XK367Details
ENEL AMERICAS SUS29274FAF18Details
ENERGY TRANSFER OPERUS29279FAA75Details
ENELIM 3625 25 MAY 27US29278GAA67Details
ENELIM 4875 14 JUN 29US29278GAK40Details
ENELIM 35 06 APR 28US29278GAF54Details
ENELIM 475 25 MAY 47US29278GAC24Details
ENELIM 225 12 JUL 31US29278GAP37Details
ENELIM 1875 12 JUL 28US29278GAN88Details
Morgan Stanley 3591US61744YAK47Details
ENELIM 1375 12 JUL 26US29278GAM06Details
ENELIM 55 15 JUN 52US29278GAY44Details
ENELIM 68 14 OCT 25US29278GAZ19Details
ENELIM 4625 15 JUN 27US29278GAW87Details
ENELIM 5 15 JUN 32US29278GAX60Details
ENELIM 425 15 JUN 25US29278GAV05Details
Morgan Stanley 3971US61744YAL20Details
MGM Resorts InternationalUS552953CD18Details
Valero Energy PartnersUS91914JAA07Details
ENELIM 775 14 OCT 52US29278GBB32Details
ENELIM 75 14 OCT 32US29278GBA58Details

Understaning ENDRA Life Use of Financial Leverage

ENDRA Life's financial leverage ratio helps determine the effect of debt on the overall profitability of the company. It measures ENDRA Life's total debt position, including all outstanding debt obligations, and compares it with ENDRA Life's equity. Financial leverage can amplify the potential profits to ENDRA Life's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if ENDRA Life is unable to cover its debt costs.
Last ReportedProjected for Next Year
Net Debt-2.4 M-2.6 M
Short and Long Term Debt Total394.4 K452.9 K
Short and Long Term Debt25.6 K24.4 K
Short Term Debt202.3 K211.5 K
Long Term Debt25.6 K24.4 K
Long Term Debt Total303.4 K269.7 K
Net Debt To EBITDA 0.25  0.33 
Debt To Equity 0.01  0.01 
Debt Equity Ratio 0.01  0.01 
Cash Flow To Debt Ratio(335.23)(318.47)
Please read more on our technical analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Fundamentals Over Time.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
-3 K
Return On Assets
(0.61)
Return On Equity
(1.20)
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.